We are now offering a NEW discounted rate of $495.* This program will prepare pharmacists to enter into a written collaborative practice agreement (CPA) with a supervising physician in accordance with Florida law.
Program Details
- Intended Audience: Pharmacists who would like to enter into a Collaborative Practice Agreement
- Universal Activity Number: 0012-0000-21-006-B04-P
- Contact Hours: 20.0 hours of ACPE continuing education for pharmacists (12.0 hours self-paced; 8-live, online)
- Program Fees: NEW! $495.00*
- Dates Available: 01/29/2021 – 01/29/2024
- Activity Type: Practice/Certificate Program
- Program Support: No outside financial support was provided.
*No refunds (for cost difference) will be given for any past registrations.
Summary
This program meets the requirements outlined in Section 465.1865, Florida Statutes for pharmacists who wish to enter into a collaborative practice agreement with a supervising physician in the State of Florida. Upon successful completion of the program, participants will earn a certificate of achievement from the University of Florida Office of Continuing Pharmacy Education. Visit the Florida Board of Pharmacy website to learn more about pharmacist requirements to enter into a Collaborative Practice Agreement.
Objectives
At the completion of this activity, the participant will be able to:
- Define ambulatory care as it pertains to pharmacists Identify common areas of practice and disease states encountered
- Describe the benefits of including pharmacists into ambulatory care teams
- Identify barriers facing ambulatory care pharmacists
- Define collaborative practice agreement
- Describe the benefits of practicing under a Collaborative Practice Agreement
- Identify potential drawbacks of a CPA
- Identify potential barriers to implementation of a CPA
- Develop a Collaborative Practice Agreement”
- Define a pharmacist collaborative practice agreement as outlined by in Chapter 64B16-31.005.
- Review requirements outlined by Chapter 465 for a pharmacist to enter into a Collaborative practice agreement.
- Review mandatory continuing education requirements required by the FL BOP for pharmacists to enter into a Collaborative Practice Agreement.
- Summarize initial and ongoing legal and practice requirements pharmacists must meet to practice under a collaborative practice agreement in the State of Florida.
- Perform patient assessments
- Order, perform, and interpret clinical and laboratory tests related to collaborative pharmacy practice.
- Evaluate and manage diseases and health conditions, including appropriate drug therapy changes, in collaboration with other health care practitioners
- Perform patient assessments
- Order, perform, and interpret clinical and laboratory tests related to collaborative pharmacy practice.
- Evaluate and manage diseases and health conditions, including appropriate drug therapy changes, in collaboration with other health care practitioners
- Identify prescribers to collaborate within the development of a CPA
- Discuss the relationship with a prescriber
- Outline required elements of a CPA and communications, documentation, and other pertinent subjects related to a CPA
- Identify ways to secure and strengthen Practitioner and Patient relationships
- Summarize Florida law and other related requirements for documenting and maintaining documentation of collaborative practice activities
- Summarize Florida law and other related requirements for communicating with patients and providers in a collaborative practice agreement
- Identify strategies or systems to support efficient documentation and communication with patients and providers
- Review successful business models for collaborative practice
- Identify what your Competitive Advantages are
- Create a marketing strategy, including a “30-second commercial” for your collaborative practice
Program Aims
Upon completion of the program the learner will be familiar with the legal and regulatory requirements associated with entering into a collaborative practice agreement, patient assessment and treatments for chronic diseases outlined in Florida law, be able to write a written collaborative practice agreement, and gain experience building a business model and marketing plan for their practice. For each of the health conditions listed below, the learner will be required to demonstrate the following competencies through interactive completion of live lectures, patient cases, and other active learning exercises:
- Perform needed patient assessment skills
- Develop and communicate plans for ordering, performing, and interpreting clinical and laboratory tests
- Evaluate and develop treatment plans for collaborative practice and communicate these to patients and providers
- List required follow up and documentation for collaborative practice
Disease States Pharmacists Can Manage in a Collaborative Practice Agreements under Florida Board of Pharmacy Rules and Regulations:
Hypertension
Hyperlipidemia
Anticoagulation
Type 2 Diabetes
Obesity
Asthma
COPD
Nicotine Dependence
HIv/AIDs
Arthritis
Opioid-Use Disorder
Program Requirements
This program includes a 12-hour fully online, self-paced lecture series and an 8-hour interactive live, online skill-building session. To earn the certificate of achievement the learner will need to successfully meet the requirements outlined below.
- Part 1: This part of the program is accredited for 12 hours of ACPE continuing education for pharmacists. This self-paced, and fully online educational program that requires the learner to complete a self-study assessment with a passing score of at least 70%.
- Part 2: This part of the program is accredited for 8-hours of ACPE continuing education for pharmacists. This live seminar in which participants discuss patient cases, draft a collaborative practice agreement, and develop a business model and marketing plan for their practice. Learners are actively engaged and receive feedback and direction from faculty experts throughout the program.
- Final assessment: Complete and pass a final assessment that requires the learner to pass with a score of at least 70%.
Acknowledgements and Disclosures
Advisory Board
Kristin Wiisanen Pharm.D., FAPhA, FCCP
Katie Vogel Anderson Pharm.D., BCACP, FCCP
Teresa E Roane PharmD, MBA, BCACP
Eric Rosenberg M.D., M.S.P.H., F.A.C.P.
Siegfried O Schmidt MD, PhD
John Gums Pharm.D., FCCP
- Rachel Shaddock, Pharm.D.
Faculty
Eric A Dietrich Pharm.D., BCACP, CPC-A, CEMC, CPB
Gary Cacciatore
Carol A Motycka Pharm.D., BCACP
Michelle Z Farland Pharm.D., CDCES
Eric F Egelund Ph.D., Pharm.D.
Leslie Hendeles Pharm.D.
Refund Policy
The University of Florida College of Pharmacy Office of Continuing Education will utilize fair and equitable policies related to refund, transfer, and extension of courses.
Accommodations for Disabilities or Special Requests
Contact us a minimum of ten working days prior to the conference so that adequate consideration may be given to your request.
Contact Us
Have a question? We can help!
The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.